Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Aug 14, 2020 7:33 PM EDT Latest News August 11, 2020 China National Medical Products Administration Approves Truvada® for HIV Pre-Exposure Prophylaxis (PrEP) August 10, 2020 Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury® (Remdesivir) for the Treatment of COVID-19 July 30, 2020 Gilead Sciences Announces Third Quarter 2020 Dividend View All Events Jul 30, 2020 at 4:30 PM EDT Second Quarter 2020 Gilead Sciences Earnings Conference Call May 6, 2020 at 10:00 AM PDT Gilead Sciences 2020 Stockholders Meeting Apr 30, 2020 at 4:30 PM EDT First Quarter 2020 Gilead Sciences Earnings Conference Call View All
